Stress Myocardial Perfusion Imaging in the Diagnosis and Prognosis of Women with Suspected Coronary Artery Disease

Cardiology in Review

Volumn 11, Issue 6, 2003, Pages 330-336

  Mieres, Jennifer H ^a,c   Shaw, Leslee J ^b  

^a NEW YORK UNIVERSITY   (United States)

^b Atlanta Cardiovasc Res Institute   (United States)

^c NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

Coronary artery disease; Myocardial perfusion imaging; Risk stratification; Women

Indexed keywords

ALGORITHM; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE PREDISPOSITION; EXERCISE ELECTROCARDIOGRAPHY; HEART MUSCLE PERFUSION; HUMAN; PROGNOSIS; REVIEW; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ALGORITHMS; CORONARY ARTERIOSCLEROSIS; DIABETIC ANGIOPATHIES; FEMALE; HEART; HUMANS; PROGNOSIS; RISK ASSESSMENT; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0242581647     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.crd.0000088275.80332.28     Document Type: Review

References (51)

1. American Heart Association. 2003 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association; 2003.
2. Shaw, LJ, Miller DD, Romeis JC, et al. Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med. 1994;120:559-556.
3. Tobin JN, Wassertheil-Smoller S, Wexler JP, et al. Sex bias in considering coronary bypass surgery. Ann Intern Med. 1987;107:19-25.
4. Douglas PS, Ginsburg GS. The evaluation of chest pain in women. N Engl J Med. 1996;334:1311-1315.
5. Steingart RM, Packer M, Hamm P, et al. Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators. N Engl J Med. 1991;325:226-230.
6. Kilaru PK, Kelly RF, Calvin JE, et al. Utilization of coronary angiography and revascularization after acute myocardial infarction in men and women risk stratified by the American College of Cardiology/American Heart association guidelines. J Am Coll Cardiol. 2000;35:974-979.
7. Mark DB, Shaw LK, Delong ER, et al. Absence of sex bias in the referral of patients for cardiac catheterization. N Engl J Med. 1994;330:1101-1106.
8. Hochleimer M. Coronary heart disease: sexual bias in referral for coronary angiogram. How does it work in a state-run health system? J Women Health Gen Based Med. 2000;9:29-34.
9. Wong CC, Froelicher ES, Bacchetti P, et al. Influence of gender on cardiovascular mortality in acute myocardial infarction patients with high indication for coronary angiography. Circulation. 1997;96:II-51-II-57.
10. Mosca L, Grundy SM, Judelson D, et al. AHA/ACC scientific statement: consensus panel statement. Guide to preventive cardiology for women. J Am Coll Cardiol. 1999;33:1751-1755.
11. Mieres JH, Shaw LJ, Hendel RC, et al. Consensus Statement from the American Society of Nuclear Cardiology Task Force on Women and Heart Disease. The role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women. J Nucl Cardiol. 2003;10:95-101.
12. Cacciabaudo JM, Hachamovitch R. Stress myocardial perfusion SPECT in women: is it the corner-stone of the noninvasive evaluation? J Nucl Med. 1998;39:756-8.
13. Goodgold HM, Rehder JG, Samuels LD. Improved interpretation of exercise T1-201 myocardial perfusion scintigraphy in women: characterization of breast attenuation artifacts. Radiology. 1987;165:361-366.
14. Hansen CL, Crabbe D, Rubin S. Lower diagnostic accuracy of thallium-201 SPECT myocardial perfusion imaging in women: an effect of smaller chamber. J Am Coll Cardiol. 1996;67:69-77.
15. Kwok Y, Kim C, Grady D, et al. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol. 1999;83:660-6.
16. Santana-Boado C, Candell-Riera J, Castell-Conesa J, et al. Diagnostic accuracy of technetium-99m-MIBI myocardial SPECT in women and men. J Nucl Med. 1998;39:751-755.
17. Taillefer R, DePuey EG, Udelson JE, et al. Comparative diagnostic accuracy of T1-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol. 1997;29:69-77.
18. Heller GV, Fossati AT. Detection of coronary artery disease in women. In: Zaret B, Beller G, eds. Nuclear Cardiology: State of the Art and Future Directions. 2nd ed. St. Louis: Mosby; 1999.
19. Friedman TD, Greene AC, Iskandrain AS, et al. exercise thallium-2091 myocardial perfusion scintigraphy in women: correlation with coronary arteriography. Am J Cardiol. 1982;49:1632-37.
20. Amanullah AM, Berman DS, Hachamovitch R, et al. Identification of severe or extensive coronary artery disease in women by adenosine technetium-99m sestamibi SPECT. Am J Cardiol. 1997;80:132-137.
21. Kong BA, Shaw L, Miller DD, et al. Comparison of accuracy for detecting coronary artery disease and side-effect profile of dipyridamole thallium-201 myocardial perfusion imaging in women versus men. Am J Cardiol. 1992;70:168-173.
22. Amanullah AM, Berman DS, Erol J, et al. Incremental prognostic value of adenosine myocardial perfusion single-photon emission computed tomography in women with suspected coronary artery disease. Am J Cardiol. 1998;82:725-730.
23. Hachamovitch R, Berman DS, Kiat H, et al. Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing. J Am Coll Cardiol. 1996;28:34-44.
24. Travin MI, Duca MD, Kline GM, et al. Relation of gender to physician use of test results and to the prognostic value of stress technetium 99m sestamibi myocardial single-photon emission computed tomography scintigraphy. Am Heart J. 1997;134:73-82.
25. Ficaro EP, Shreve PD, Kirtzman JN, et al. Evaluation of attenuation corrected cardiac SPECT perfusion imaging in women. Circulation. 1996; Suppl 94.8:1-13.s.
26. Berman DS, Kang X, Hayes SW, et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol. 2003;41:1125-1133.
27. Giri S, Shaw LJ, Murthy DR, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation. 2002;105:32-40.
28. Amanullah AM, Kiat H, Hachamovitch R, et al. Impact of myocardial perfusion single-photon emission computed tomography on referral to catheterization of the very elderly. Is there evidence of gender-related referral bias? J Am Coll Cardiol. 1996;28:680-686.
29. Gibbons RJ, Hodge DO, Berman DS, et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation. 1999;100:2140-2145.
30. Gibbons RJ, Chatterjee K, Daley J, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol. 1999;3:2092-2197.
31. Galassi AR, Azzarelli S, Tomaselli A, et al. Incremental prognostic value of technetium-99m-tetrofosmin exercise myocardial perfusion imaging for predicting outcomes in patients with suspected of known coronary artery disease. Am J Cardiol. 2001;88:101-106.
32. Vanzetto G, Ormezzano O, Farget D, et al. Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients: study in 1137 patients with 6 year follow-up. Circulation. 1999;100:1521-1527.
33. Olmos LI, Dakik H, Gordon R, et al. Long-term prognostic value of exercise echocardiography compared with exercise 201, T1, ECG, and clinical variables in patients evaluated for coronary artery disease. Circulation. 1998;98:2679-2686.
34. Alkeylani A, Miller DD, Shaw LJ, et al. Influence of race on the prediction of cardiac events with stress technetium-99m sestamibi tomographic imaging in patients with stable angina pectoris. Am J Cardiol. 1998;81:293-297.
35. Snader CE, Marwick TH, Pashkow FJ, et al. Importance of estimated functional capacity as a predictor of all-cause mortality among patients referred for exercise thallium single-photon emission computed tomography: report of 3, 400 patients from a single center. J Am Coll Cardiol. 1997;30:641-648.
36. Boyne TS, Koplan BA, Parsons WJ, et al. Predicting adverse outcome with exercise SPECT technetium-99m-sestamibi imaging in patients with suspected or known coronary artery disease. Am J Cardiol. 1997;79:270-274.
37. Geleijnse ML, Elhendy A, van Domburg RT, et al. Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both? Circulation. 1997;96:137-147.
38. Heller GV, Herman SD, Travin MI, et al. Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions. J Am Coll Cardiol. 1995;26:1202-1208.
39. Machecourt J, Longere P, Pagret D, et al. Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect. Study in 1, 926 patients with follow-up at 33 months. J Am Coll Cardiol. 1994;23:1096-1106.
40. Kamal AM, Fattah AA, Pancholy S, et al. Prognostic value of adenosine single-photon emission computed tomographic thallium imaging in medically treated patients with angiographic evidence of coronary artery disease. J Nucl Cardiol. 1994;1:254-261.
41. Stratman HG, Tamesis BR, Younis LT, et al. Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise. Am J Cardiol. 1994;73:647-652.
42. Stratman HG, Williams GA, Wittry MD, et al. Exercise technetium-99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation. 1994;89:615-622.
43. Groutars RG, Verzijbergen JF, Muner AJ, et al. Prognostic value and quality of life in patients with normal rest thallium-201/stress technetium 99m-tetreosofmin dual isotope myocardial SPECT. J Nucl Cardiol. 2000;7:333-341.
44. Soman P, Parsons A, Lahiri N, et al. The prognostic value of a normal Tc-99m sestamibi SPECT study in suspected coronary artery disease. J Nucl Cardiol. 1999;6:252-256.
45. Yao SS, Rozanski A. Principal uses of myocardial perfusion scintigraphy in the management of patients with known or suspected coronary artery disease. Prog Cardiovasc Dis. 2001;43:281-302.
46. Hendel R, Chen M, L'Italien G, et al. Sex differences in perioperative and long term cardiac event-free survival in vascular surgery patients. Circulation. 1995;91:1044-1051.
47. Marwick T, Shaw L, Lauer M, et al. The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease: Economics of Noninvasive Diagnosis (END) Study Group. Am J Med. 1999;106:172-178.
48. Pancholy S, Fattah A, Kamal A, et al. Independent and incremental prognostic value of exercise thallium single-photon emission tomographic imaging in women. J Nucl Cardiol. 1995;2:110-116.
49. Sharir T, Germano G, Kavanagh PB, et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation. 1999;100:1035-1042.
50. Barret-Connor EL, Cohen BA, Wingard DL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than men? The Rancho Bernardo study. JAMA. 1991;265:627-631.
51. Kang X, Berman DS, Lewin HC, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J. 1999;138:1025-1032.